MRNA
Moderna, Inc. · Healthcare
Director Noubar Afeyan sold $1.7M of Moderna, Inc.
Sold$1,735,200
$173.52Price
10,000Shares
What MRNA did after the filing
- The stock from Mon, Dec 5 open, $180.99
- +5.2%
- S&P 500, same days
- −3.3%
Measured over 30 trading days, to the Jan 19 close.
Traded Wed, Nov 30. Filed Fri, Dec 2, 7:30 PM ET, after the close. Returns use the Dec 5 open and the Jan 19 close. Not investment advice.